Is Gynostemma Exercise Performance Randomized Trial safe?

The current Migaku evidence database contains 2 reusable source documents for Gynostemma Exercise Performance Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - pentaphyllum, participants had significantly lower leptin and blood glucose levels and improved time trial performance over 20 km, which corresponded with a higher muscle oxygen flux compared to placebo. [Nayyar D (2023); evidence level 4] - Muscle AMPK Thr172 phosphorylation significantly increased after 60 min exercise following G. [Nayyar D (2023); evidence level 4] - AMPK Thr172 phosphorylation levels relative to total AMPK increased earlier following exercise with G. [Nayyar D (2023); evidence level 4] - pentaphyllum ) on exercise performance, AMP-activated protein kinase (AMPK), and mitochondrial signaling in human muscle. [Nayyar D (2023); evidence level 4] - 1 2 Regular exercise enhances endurance and decreases the risk of several chronic diseases, such as type 2 diabetes, obesity, hypertension, coronary heart disease, sarcopenia, and cardiovascular diseases []. [Kim Yoon Hee (2022); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.